PALAU PHARMA

Local Time
Last Revised
10.21.2011

Latest News

10.03.2011Palau Pharma sells to Draconis Pharma its Drug Discovery Unit and will focus on the development of its late-stage clinical pipeline

12.17.2010Palau Pharma Initiates Phase II Clinical Trial of its histamine H₄ receptor antagonist UR-63325

09.01.2010Palau Pharma, member of the Board of Directors of the European Biopharmaceutical Enterprises

06.08.2010Palau Pharma reports positive First-in-Man clinical trial results for its histamine H₄ receptor antagonist UR-63325

Corporate Information

Meet Us At

31October

09January

19March

BioEurope

October 31 - November 2, 2011

Duesseldorf
Germany